Impact of the 2018 HER2 Testing Focused Update on Classification of dual-probe ISH Groups

被引：0
|
作者：
Schmolze, Daniel [1 ]
Apple, Sophia [2 ]
机构：
[1] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
249
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Evaluation of AI-Integrated HER2 Dual ISH Detection Systems in Invasive Breast Carcinoma
    Bakoglu, Nilay
    Cesmecioglu, Emine
    Ohnishi, Takashi
    Ohnishi, Chie
    Ross, Dara
    Yagi, Yukako
    LABORATORY INVESTIGATION, 2024, 104 (03) : S115 - S117
  • [42] Comparison of HER2 dual-color and fluorescence ISH in breast cancer: a study of equivocal cases
    Shao, T.
    Wood, M.
    Wing, A.
    Hnatovska, M.
    Mendes, M.
    Mullen, J. B.
    Chang, M. C.
    BREAST, 2015, 24 : S123 - S124
  • [43] Silver-enhanced In Situ Hybridization (SISH) detection assay and Inform HER2 Dual ISH DNA probe cocktail assay (DSISH) for HER2 gene status determination in breast carcinoma: A new experience
    Patakiouta, F.
    Theodorou, V.
    Koumpanaki, M-M
    Triantafillidou, E.
    Minotakis, D.
    Fotiou, C.
    Papakotoulas, P.
    Andreadis, C.
    Sibilidis, G.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 266 - 266
  • [44] Single probe brightfield ISH is a robust and reproducible technique for the assessment of HER2 status in breast cancer.
    Di Palma, S.
    Collins, N.
    Mottolese, M.
    Schmitt, F.
    Sapino, A.
    Kapranos, N.
    Boecker, W.
    Bilous, M.
    Isola, J.
    VIRCHOWS ARCHIV, 2007, 451 (02) : 304 - 305
  • [45] HER2 FISH Testing with RAI1 Alternate Probe Will Resolve HER2 Status in Majority of Equivocal Cases
    Hui, Ling
    Geiersbach, Katherine
    Downs-Kelly, Ennn
    Factor, Rachel E.
    Gulbahce, H. Evin
    MODERN PATHOLOGY, 2016, 29 : 46A - 46A
  • [46] HER2 FISH Testing with RAI1 Alternate Probe Will Resolve HER2 Status in Majority of Equivocal Cases
    Hui, Ling
    Geiersbach, Katherine
    Downs-Kelly, Erinn
    Factor, Rachel E.
    Gulbahce, H. Evin
    LABORATORY INVESTIGATION, 2016, 96 : 46A - 46A
  • [47] Risk Classification For Breast Cancer Diagnosis Using HER2 Testing
    Aktan, Pinar Ece
    Hatipoglu, Gokhan
    Arica, Nafiz
    2016 24TH SIGNAL PROCESSING AND COMMUNICATION APPLICATION CONFERENCE (SIU), 2016, : 2133 - 2136
  • [48] Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases
    Liu, Zhi-Hua
    Wang, Kun
    Lin, Dan-Yi
    Xu, Jie
    Chen, Jie
    Long, Xiao-Yu
    Ge, Yan
    Luo, Xin-Lan
    Zhang, Ke-Ping
    Liu, Yan-Hui
    Xu, Fang-Ping
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (01) : 51 - 57
  • [49] Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases
    Zhi-Hua Liu
    Kun Wang
    Dan-Yi Lin
    Jie Xu
    Jie Chen
    Xiao-Yu Long
    Yan Ge
    Xin-Lan Luo
    Ke-Ping Zhang
    Yan-Hui Liu
    Fang-Ping Xu
    Breast Cancer Research and Treatment, 2019, 175 : 51 - 57
  • [50] Predictive markers in breast cancer: An update on ER and HER2 testing and reporting
    Calhoun, Benjamin C.
    Collins, Laura C.
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2015, 32 (05) : 362 - 369
12345